Q: Why should Medafor negotiate when the company is currently "not for sale"? A: It would be stupid to do so.
Q: Why open your records to someone trying to screw you? A: It would be stupid to do so.
What appears to be a real possibility though is that in 2013, after BioGlue goes off patent and assuming no major sales from new products, that CRY could be a break even company (if it lost about $12M in sales and had its gross margin cut back form 85% to 70%). This possibility goes to the substance of my question. This is a valid question. A stock analyst would know what I'm talking about and adjust their reports accordingly. This makes CRY stock unattractive to Medafor shareholders. By the way, all my sell orders placed last Thursday, so that timing worked out rather well anyway.